Author:
Zhu Aiguo,Li Xin,Wang Jian
Funder
Tianjin Health Technology Project
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,General Medicine
Reference32 articles.
1. Almstedt E, Elgendy R, Hekmati N, Rosen E, Warn C, Olsen TK, Dyberg C, Doroszko M, Larsson I, Sundstrom A, Arsenian Henriksson M, Pahlman S, Bexell D, Vanlandewijck M, Kogner P, Jornsten R, Krona C, Nelander S (2020) Integrative discovery of treatments for high-risk neuroblastoma. Nat Commun 11:71
2. Anderson J, Majzner RG, Sondel PM (2022) Immunotherapy of neuroblastoma: facts and hopes. Clin Cancer Res 28:3196–3206
3. Armideo E, Callahan C, Madonia L (2017) Immunotherapy for high-risk neuroblastoma: management of side effects and complications. J Adv Pract Oncol 8:44–55
4. Badia IMP, Velez Santiago J, Braunger J, Geiss C, Dimitrov D, Muller-Dott S, Taus P, Dugourd A, Holland CH, Ramirez Flores RO, Saez-Rodriguez J (2022) decoupleR: ensemble of computational methods to infer biological activities from omics data. Bioinform Adv 2:vbac016
5. Becht E, Giraldo NA, Lacroix L, Buttard B, Elarouci N, Petitprez F, Selves J, Laurent-Puig P, Sautes-Fridman C, Fridman WH, de Reynies A (2016) Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression. Genome Biol 17:218
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献